EDGAR Filing Documents for 0001387131-13-004242

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001387131-13-004242

Filing Date

2013-11-13

Accepted

2013-11-13 17:19:31

Documents

Period of Report

2013-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	admp-10q_093013.htm	10-Q	496900
2	CERTIFICATION OF CHIEF EXECUTIVE OFFICER	ex31_1.htm	EX-31.1	18534
3	CERTIFICATION OF VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER	ex31_2.htm	EX-31.2	18977
4	CERFICATION OF CHIEF EXECUTIVE OFFICER	ex32_1.htm	EX-32.1	8761
5	CERTIFICATION OF VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER	ex32_2.htm	EX-32.2	8573
	Complete submission text file	0001387131-13-004242.txt		3316961

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	admp-20130930.xml	EX-101.INS	428949
7	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	admp-20130930.xsd	EX-101.SCH	25194
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	admp-20130930_cal.xml	EX-101.CAL	35914
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	admp-20130930_def.xml	EX-101.DEF	110099
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	admp-20130930_lab.xml	EX-101.LAB	212816
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	admp-20130930_pre.xml	EX-101.PRE	169268

Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130

Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400

Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)